Impact of Fluid Resuscitation on Venous Congestion in Cardiac Critically-ill Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Vienna
About this trial
The objective of this study is to assess how fluid resuscitation, in the context of fluid responsiveness, affects the incidence and progression of systemic venous congestion in critically ill cardiac patients. Additionally, the study aims to evaluate the impact on clinical outcomes, with a particular focus on acute kidney dysfunction. This assessment will utilize the VExUS score in conjunction with comprehensive bedside echocardiographic evaluations.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age above 18 years
Admission to cardiac intensive care unit
Disqualifiers
None
Trial population
Cardiac critically ill patients (mainly post cardiac surgery)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
VExUS & Cardiac Ultrasound
Diagnostic testThe VExUS system provides a semi-quantitative assessment of systemic venous congestion by integrating ultrasound evaluations of the inferior vena cava diameter, hepatic vein flow, portal pulsatility, and renal venous flow, offering a practical and comprehensive bedside tool
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Venous congestion
Venous congestion as assessed by the VExUS score at ICU admission, and on each of the first seven postoperative days.
Time frame
7 days2
Acute kidney injury
Acute kidney injury (AKI), defined through the KDIGO criteria, within seven and twenty-eight days of ICU admission.
Time frame
Twenty-eight daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: